@misc{indiciae05d3dcd2b869,
  title = {Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group.},
  author = {A Le Cesne and I Judson and D Crowther and S Rodenhuis and H J Keizer and Q Van Hoesel and J Y Blay and J Frisch and M Van Glabbeke and C Hermans and A Van Oosterom and T Tursz and J Verweij},
  year = {2000},
  doi = {10.1200/jco.2000.18.14.2676},
  url = {https://pubmed.ncbi.nlm.nih.gov/10894866/},
  note = {Source identifier: 10894866}
}